Literature DB >> 24082079

Pseudomonas aeruginosa outer membrane vesicles modulate host immune responses by targeting the Toll-like receptor 4 signaling pathway.

Kelei Zhao1, Xin Deng, Chuan He, Bisong Yue, Min Wu.   

Abstract

Bacteria can naturally secrete outer membrane vesicles (OMVs) as pathogenic factors, while these vesicles may also serve as immunologic regulators if appropriately prepared. However, it is largely unknown whether Pseudomonas aeruginosa OMVs can activate inflammatory responses and whether immunization with OMVs can provide immune protection against subsequent infection. We purified and identified OMVs, which were then used to infect lung epithelial cells in vitro as well as C57BL/6J mice to investigate the immune response and the underlying signaling pathway. The results showed that OMVs generated from P. aeruginosa wild-type strain PAO1 were more cytotoxic to alveolar epithelial cells than those from quorum-sensing (QS)-deficient strain PAO1-ΔlasR. The levels of Toll-like receptor 4 (TLR4) and proinflammatory cytokines, including interleukin-1β (IL-1β) and IL-6, increased following OMV infection. Compared with lipopolysaccharide (LPS), lysed OMVs in which the membrane structures were broken induced a weak immune response. Furthermore, expression levels of TLR4-mediated responders (i.e., cytokines) were markedly downregulated by the TLR4 inhibitor E5564. Active immunization with OMVs or passive transfer of sera with a high cytokine quantity acquired from OMV-immunized mice could protect healthy mice against subsequent lethal PAO1 challenges (1.5 × 10(11) CFU). Collectively, these findings indicate that naturally secreted P. aeruginosa OMVs may trigger significant inflammatory responses via the TLR4 signaling pathway and protect mice against pseudomonal lung infection.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24082079      PMCID: PMC3837971          DOI: 10.1128/IAI.01008-13

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  52 in total

1.  A new mathematical model for relative quantification in real-time RT-PCR.

Authors:  M W Pfaffl
Journal:  Nucleic Acids Res       Date:  2001-05-01       Impact factor: 16.971

Review 2.  Toll-like receptor signalling.

Authors:  Shizuo Akira; Kiyoshi Takeda
Journal:  Nat Rev Immunol       Date:  2004-07       Impact factor: 53.106

3.  Escherichia coli FPG and human OGG1 reduce DNA damage and cytotoxicity by BCNU in human lung cells.

Authors:  Ying-Hui He; Yi Xu; Masayoshi Kobune; Min Wu; Mark R Kelley; William J Martin
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2002-01       Impact factor: 5.464

4.  Inhibition of endotoxin response by e5564, a novel Toll-like receptor 4-directed endotoxin antagonist.

Authors:  Maureen Mullarkey; Jeffrey R Rose; John Bristol; Tsutomu Kawata; Akufumi Kimura; Seiichi Kobayashi; Melinda Przetak; Jesse Chow; Fabian Gusovsky; William J Christ; Daniel P Rossignol
Journal:  J Pharmacol Exp Ther       Date:  2003-03       Impact factor: 4.030

Review 5.  Regulation of the Escherichia coli sigma-dependent envelope stress response.

Authors:  Benjamin M Alba; Carol A Gross
Journal:  Mol Microbiol       Date:  2004-05       Impact factor: 3.501

Review 6.  New concepts of the pathogenesis of cystic fibrosis lung disease.

Authors:  R C Boucher
Journal:  Eur Respir J       Date:  2004-01       Impact factor: 16.671

7.  Helicobacter pylori outer membrane vesicles modulate proliferation and interleukin-8 production by gastric epithelial cells.

Authors:  Salim Ismail; Mark B Hampton; Jacqueline I Keenan
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

8.  Expression and involvement of Toll-like receptors (TLR)2, TLR4, and CD14 in monocyte TNF-alpha production induced by lipopolysaccharides from Neisseria meningitidis.

Authors:  Mohammad Reza Mirlashari; Torstein Lyberg
Journal:  Med Sci Monit       Date:  2003-08

9.  TLR9 signals after translocating from the ER to CpG DNA in the lysosome.

Authors:  Eicke Latz; Annett Schoenemeyer; Alberto Visintin; Katherine A Fitzgerald; Brian G Monks; Cathrine F Knetter; Egil Lien; Nadra J Nilsen; Terje Espevik; Douglas T Golenbock
Journal:  Nat Immunol       Date:  2004-01-11       Impact factor: 25.606

10.  Neisseria lactamica protects against experimental meningococcal infection.

Authors:  Kerry J Oliver; Karen M Reddin; Philippa Bracegirdle; Michael J Hudson; Ray Borrow; Ian M Feavers; Andrew Robinson; Keith Cartwright; Andrew R Gorringe
Journal:  Infect Immun       Date:  2002-07       Impact factor: 3.441

View more
  19 in total

Review 1.  Immune modulation by bacterial outer membrane vesicles.

Authors:  Maria Kaparakis-Liaskos; Richard L Ferrero
Journal:  Nat Rev Immunol       Date:  2015-05-15       Impact factor: 53.106

2.  Pathogenesis Mediated by Bacterial Membrane Vesicles.

Authors:  William J Gilmore; Natalie J Bitto; Maria Kaparakis-Liaskos
Journal:  Subcell Biochem       Date:  2021

3.  Atg7 enhances host defense against infection via downregulation of superoxide but upregulation of nitric oxide.

Authors:  Xuefeng Li; Yan Ye; Xikun Zhou; Canhua Huang; Min Wu
Journal:  J Immunol       Date:  2014-12-22       Impact factor: 5.422

Review 4.  Membrane vesicle production by Chlamydia trachomatis as an adaptive response.

Authors:  Kyla M Frohlich; Ziyu Hua; Alison J Quayle; Jin Wang; Maria E Lewis; Chau-wen Chou; Miao Luo; Lyndsey R Buckner; Li Shen
Journal:  Front Cell Infect Microbiol       Date:  2014-06-10       Impact factor: 5.293

5.  A novel chemosynthetic peptide with β-sheet motif efficiently kills Klebsiella pneumoniae in a mouse model.

Authors:  Shirui Tan; Changpei Gan; Rongpeng Li; Yan Ye; Shuang Zhang; Xu Wu; Yi Yan Yang; Weimin Fan; Min Wu
Journal:  Int J Nanomedicine       Date:  2015-02-09

Review 6.  Outer membrane vesicles as platform vaccine technology.

Authors:  Leo van der Pol; Michiel Stork; Peter van der Ley
Journal:  Biotechnol J       Date:  2015-09       Impact factor: 4.677

7.  Dual-seq transcriptomics reveals the battle for iron during Pseudomonas aeruginosa acute murine pneumonia.

Authors:  F Heath Damron; Amanda G Oglesby-Sherrouse; Angela Wilks; Mariette Barbier
Journal:  Sci Rep       Date:  2016-12-16       Impact factor: 4.379

8.  Prioritization of potential vaccine targets using comparative proteomics and designing of the chimeric multi-epitope vaccine against Pseudomonas aeruginosa.

Authors:  Vandana Solanki; Monalisa Tiwari; Vishvanath Tiwari
Journal:  Sci Rep       Date:  2019-03-27       Impact factor: 4.379

Review 9.  Extracellular Vesicles: Role in Inflammatory Responses and Potential Uses in Vaccination in Cancer and Infectious Diseases.

Authors:  João Henrique Campos; Rodrigo Pedro Soares; Kleber Ribeiro; André Cronemberger Andrade; Wagner Luiz Batista; Ana Claudia Torrecilhas
Journal:  J Immunol Res       Date:  2015-08-25       Impact factor: 4.818

10.  Genes as early responders regulate quorum-sensing and control bacterial cooperation in Pseudomonas aeruginosa.

Authors:  Kelei Zhao; Yi Li; Bisong Yue; Min Wu
Journal:  PLoS One       Date:  2014-07-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.